High Efficacy of Gemcitabine and Cisplatin Plus Trastuzumab in Patients with HER2-overexpressing Metastatic Breast Cancer: A Phase II Study

Combination chemotherapy with gemcitabine and cisplatin plus trastuzumab is well tolerated and active in patients with HER2 overexpressing MBC, even after prior exposure to anthracyclines and taxanes.